290 related articles for article (PubMed ID: 9493635)
1. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
Rawes JA; Calabrese VP; Khan OA; DeVries GH
Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
Matà S; Lolli F; Söderström M; Pinto F; Link H
Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
[TBL] [Abstract][Full Text] [Related]
3. T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.
Holmøy T; Vandvik B; Vartdal F
Mult Scler; 2003 Jun; 9(3):228-34. PubMed ID: 12814167
[TBL] [Abstract][Full Text] [Related]
4. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
Dorta-Contreras A; Silva-Somoza R
Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
[TBL] [Abstract][Full Text] [Related]
5. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
6. Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases.
Traugott U; Raine CS
Neurology; 1981 Jun; 31(6):695-700. PubMed ID: 7017459
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
Domínguez-Mozo MI; Nieto-Guerrero A; Pérez-Pérez S; García-Martínez MÁ; Arroyo R; Álvarez-Lafuente R
Front Immunol; 2020; 11():2142. PubMed ID: 33072077
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis.
Svarcová J; Fialová L; Bartos A; Steinbachová M; Malbohan I
Eur J Neurol; 2008 Nov; 15(11):1173-9. PubMed ID: 18973612
[TBL] [Abstract][Full Text] [Related]
10. Detection and isolation of immune complexes in multiple sclerosis cerebrospinal fluid.
Coyle PK
J Neuroimmunol; 1987 May; 15(1):97-107. PubMed ID: 3571487
[TBL] [Abstract][Full Text] [Related]
11. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases.
Page N; Perruisseau G; Steck AJ
J Neurol Sci; 1983 Jul; 60(1):23-30. PubMed ID: 6192219
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases.
Matsiota P; Blancher A; Doyon B; Guilbert B; Clanet M; Kouvelas ED; Avrameas S
Ann Inst Pasteur Immunol; 1988; 139(1):99-108. PubMed ID: 3258758
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ
Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187
[TBL] [Abstract][Full Text] [Related]
14. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.
García-Merino A; Persson MA; Ernerudh J; Díaz-Gil JJ; Olsson T
J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1066-70. PubMed ID: 2428940
[TBL] [Abstract][Full Text] [Related]
15. Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases.
Suchanek G; Kristoferitsch W; Stanek G; Bernheimer H
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):160-8. PubMed ID: 3577478
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
Xiao BG; Linington C; Link H
J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
[TBL] [Abstract][Full Text] [Related]
17. Screening of multiple sclerosis cerebrospinal fluid for autoantibodies.
Brankin B; Allen IV; Hawkins SA; Wisdom GB
J Neurol Sci; 1988 Mar; 84(1):29-40. PubMed ID: 3367151
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
19. Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients.
Kostulas VK; Link H; Lefvert AK
Arch Neurol; 1987 Oct; 44(10):1041-4. PubMed ID: 3632376
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with multiple sclerosis.
Kölln J; Zhang Y; Thai G; Demetriou M; Hermanowicz N; Duquette P; van den Noort S; Qin Y
J Immunol; 2010 Aug; 185(3):1968-75. PubMed ID: 20610654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
